 Kathryn Collins
Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 26 | 2022 | 659 | 4.410 |
Why?
| | Cryosurgery | 14 | 2018 | 52 | 4.000 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 13 | 2012 | 28 | 3.330 |
Why?
| | Tachycardia, Ventricular | 12 | 2023 | 152 | 3.210 |
Why?
| | Pacemaker, Artificial | 8 | 2021 | 107 | 2.680 |
Why?
| | Electrophysiologic Techniques, Cardiac | 21 | 2019 | 71 | 2.490 |
Why?
| | Catheter Ablation | 21 | 2022 | 291 | 2.470 |
Why?
| | Heart Conduction System | 9 | 2020 | 82 | 2.300 |
Why?
| | Wolff-Parkinson-White Syndrome | 10 | 2020 | 16 | 2.220 |
Why?
| | Defibrillators, Implantable | 9 | 2020 | 285 | 1.900 |
Why?
| | Electrocardiography | 20 | 2023 | 560 | 1.840 |
Why?
| | Arrhythmias, Cardiac | 13 | 2020 | 279 | 1.710 |
Why?
| | Tachycardia, Supraventricular | 8 | 2022 | 42 | 1.600 |
Why?
| | Device Removal | 3 | 2021 | 128 | 1.460 |
Why?
| | Cardiac Pacing, Artificial | 6 | 2017 | 79 | 1.260 |
Why?
| | Ventricular Premature Complexes | 2 | 2022 | 26 | 1.180 |
Why?
| | Heart Rate | 6 | 2019 | 701 | 1.160 |
Why?
| | Cicatrix | 2 | 2018 | 50 | 0.950 |
Why?
| | Electrodes, Implanted | 3 | 2013 | 92 | 0.910 |
Why?
| | Adolescent | 44 | 2023 | 17889 | 0.880 |
Why?
| | Child | 51 | 2023 | 18488 | 0.870 |
Why?
| | Pediatrics | 6 | 2020 | 986 | 0.840 |
Why?
| | Retrospective Studies | 45 | 2023 | 12608 | 0.830 |
Why?
| | Cardiac Surgical Procedures | 6 | 2018 | 413 | 0.800 |
Why?
| | Treatment Outcome | 35 | 2022 | 9159 | 0.790 |
Why?
| | Death, Sudden, Cardiac | 7 | 2020 | 160 | 0.790 |
Why?
| | Echocardiography, Transesophageal | 1 | 2021 | 89 | 0.720 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 2021 | 48 | 0.710 |
Why?
| | Risk Assessment | 8 | 2020 | 2987 | 0.710 |
Why?
| | Electric Countershock | 5 | 2015 | 104 | 0.690 |
Why?
| | Long QT Syndrome | 3 | 2014 | 59 | 0.670 |
Why?
| | Tachycardia | 6 | 2016 | 49 | 0.650 |
Why?
| | Esthetics | 1 | 2018 | 37 | 0.640 |
Why?
| | Fontan Procedure | 4 | 2012 | 156 | 0.630 |
Why?
| | Heart Atria | 3 | 2017 | 110 | 0.630 |
Why?
| | Female | 61 | 2022 | 59913 | 0.630 |
Why?
| | Equipment Failure | 3 | 2013 | 109 | 0.620 |
Why?
| | Anesthesia | 1 | 2019 | 119 | 0.600 |
Why?
| | Humans | 91 | 2023 | 115587 | 0.600 |
Why?
| | Heart Valve Diseases | 2 | 2020 | 116 | 0.590 |
Why?
| | Equipment Failure Analysis | 1 | 2017 | 135 | 0.560 |
Why?
| | Male | 58 | 2021 | 55949 | 0.560 |
Why?
| | Heart Valve Prosthesis Implantation | 3 | 2017 | 169 | 0.550 |
Why?
| | Tetralogy of Fallot | 5 | 2018 | 85 | 0.530 |
Why?
| | Anti-Arrhythmia Agents | 7 | 2021 | 106 | 0.530 |
Why?
| | Pre-Excitation Syndromes | 1 | 2015 | 4 | 0.520 |
Why?
| | Transposition of Great Vessels | 3 | 2013 | 29 | 0.500 |
Why?
| | Heart Block | 4 | 2008 | 38 | 0.500 |
Why?
| | Follow-Up Studies | 15 | 2020 | 4440 | 0.480 |
Why?
| | Atrial Flutter | 4 | 2017 | 25 | 0.470 |
Why?
| | Atrial Fibrillation | 4 | 2018 | 325 | 0.470 |
Why?
| | Mitral Valve | 1 | 2014 | 84 | 0.450 |
Why?
| | Axilla | 2 | 2010 | 39 | 0.430 |
Why?
| | Cardiology | 3 | 2014 | 260 | 0.420 |
Why?
| | Foreign Bodies | 1 | 2013 | 99 | 0.410 |
Why?
| | Aortic Valve | 2 | 2020 | 342 | 0.400 |
Why?
| | Heart Ventricles | 4 | 2009 | 712 | 0.370 |
Why?
| | Fetal Diseases | 2 | 2012 | 148 | 0.370 |
Why?
| | Defibrillators | 1 | 2010 | 16 | 0.370 |
Why?
| | Atrioventricular Node | 2 | 2010 | 14 | 0.370 |
Why?
| | Recurrence | 7 | 2019 | 952 | 0.360 |
Why?
| | Child, Preschool | 20 | 2020 | 9133 | 0.360 |
Why?
| | Prosthesis Implantation | 2 | 2013 | 139 | 0.360 |
Why?
| | Tachycardia, Reciprocating | 3 | 2017 | 6 | 0.350 |
Why?
| | Quality of Life | 2 | 2018 | 2385 | 0.350 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2010 | 39 | 0.340 |
Why?
| | Cosmetic Techniques | 1 | 2009 | 11 | 0.340 |
Why?
| | Calsequestrin | 2 | 2020 | 7 | 0.340 |
Why?
| | Atrioventricular Block | 4 | 2011 | 37 | 0.340 |
Why?
| | Tachycardia, Ectopic Junctional | 1 | 2009 | 4 | 0.330 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2010 | 51 | 0.330 |
Why?
| | Domperidone | 1 | 2008 | 1 | 0.330 |
Why?
| | Cardiac Electrophysiology | 2 | 2020 | 12 | 0.320 |
Why?
| | Magnetocardiography | 1 | 2008 | 2 | 0.310 |
Why?
| | Young Adult | 14 | 2021 | 10470 | 0.300 |
Why?
| | Pulmonary Valve | 3 | 2018 | 90 | 0.290 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2022 | 366 | 0.290 |
Why?
| | Coronary Vessel Anomalies | 1 | 2007 | 30 | 0.290 |
Why?
| | Adult | 28 | 2021 | 30718 | 0.280 |
Why?
| | Infant | 18 | 2020 | 7979 | 0.270 |
Why?
| | Electrocardiography, Ambulatory | 3 | 2021 | 54 | 0.260 |
Why?
| | Decision Making | 1 | 2011 | 791 | 0.250 |
Why?
| | Accessory Atrioventricular Bundle | 3 | 2015 | 11 | 0.240 |
Why?
| | Societies, Medical | 4 | 2016 | 684 | 0.240 |
Why?
| | Echocardiography | 4 | 2016 | 558 | 0.230 |
Why?
| | Bundle of His | 4 | 2010 | 16 | 0.220 |
Why?
| | Infant, Newborn | 11 | 2020 | 5077 | 0.220 |
Why?
| | Ventricular Dysfunction, Right | 2 | 2018 | 222 | 0.220 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2014 | 113 | 0.210 |
Why?
| | Syncope | 1 | 2023 | 36 | 0.210 |
Why?
| | Time Factors | 10 | 2019 | 6165 | 0.210 |
Why?
| | Risk Factors | 13 | 2020 | 8697 | 0.210 |
Why?
| | Catheters | 1 | 2022 | 66 | 0.200 |
Why?
| | Practice Patterns, Physicians' | 1 | 2010 | 1180 | 0.200 |
Why?
| | Registries | 5 | 2018 | 1770 | 0.190 |
Why?
| | Sensitivity and Specificity | 5 | 2015 | 1718 | 0.190 |
Why?
| | Cardiomyopathies | 3 | 2014 | 303 | 0.190 |
Why?
| | Fetal Heart | 1 | 2021 | 35 | 0.190 |
Why?
| | Heart Transplantation | 2 | 2003 | 671 | 0.180 |
Why?
| | Electrophysiology | 2 | 2016 | 202 | 0.180 |
Why?
| | Prevalence | 3 | 2015 | 2264 | 0.180 |
Why?
| | Child of Impaired Parents | 1 | 2020 | 40 | 0.170 |
Why?
| | California | 2 | 2013 | 367 | 0.170 |
Why?
| | Homozygote | 1 | 2020 | 186 | 0.170 |
Why?
| | Heterozygote | 1 | 2020 | 252 | 0.170 |
Why?
| | Colorado | 4 | 2019 | 4113 | 0.170 |
Why?
| | Preoperative Care | 3 | 2018 | 318 | 0.160 |
Why?
| | Interprofessional Relations | 2 | 2020 | 258 | 0.160 |
Why?
| | International Cooperation | 2 | 2016 | 174 | 0.160 |
Why?
| | Mutation, Missense | 1 | 2020 | 296 | 0.160 |
Why?
| | Survival Rate | 3 | 2020 | 1650 | 0.150 |
Why?
| | Parent-Child Relations | 1 | 2020 | 234 | 0.150 |
Why?
| | Death, Sudden | 1 | 2017 | 33 | 0.150 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 1 | 2018 | 59 | 0.150 |
Why?
| | Cardiac Catheterization | 2 | 2013 | 536 | 0.150 |
Why?
| | Heart Arrest | 2 | 2020 | 289 | 0.150 |
Why?
| | Prognosis | 3 | 2018 | 3339 | 0.140 |
Why?
| | Exercise Test | 3 | 2020 | 539 | 0.140 |
Why?
| | Education, Medical | 1 | 2020 | 225 | 0.140 |
Why?
| | Aortic Valve Stenosis | 1 | 2020 | 253 | 0.140 |
Why?
| | Prospective Studies | 5 | 2018 | 6264 | 0.130 |
Why?
| | Patient Selection | 3 | 2015 | 654 | 0.130 |
Why?
| | Stroke Volume | 2 | 2016 | 509 | 0.130 |
Why?
| | Students, Medical | 1 | 2020 | 277 | 0.130 |
Why?
| | Sympathectomy | 1 | 2015 | 6 | 0.130 |
Why?
| | Causality | 1 | 2015 | 106 | 0.120 |
Why?
| | Vectorcardiography | 1 | 2014 | 5 | 0.120 |
Why?
| | Age Distribution | 1 | 2015 | 341 | 0.120 |
Why?
| | Sex Distribution | 1 | 2015 | 337 | 0.120 |
Why?
| | Middle Aged | 14 | 2020 | 26999 | 0.120 |
Why?
| | Anesthesia, General | 1 | 2014 | 44 | 0.120 |
Why?
| | Cardiography, Impedance | 1 | 2014 | 6 | 0.120 |
Why?
| | Health Personnel | 1 | 2020 | 581 | 0.120 |
Why?
| | Ventricular Function, Left | 2 | 2022 | 467 | 0.120 |
Why?
| | Age Factors | 5 | 2016 | 2907 | 0.120 |
Why?
| | Shock, Cardiogenic | 1 | 2014 | 53 | 0.120 |
Why?
| | Cardiac Resynchronization Therapy Devices | 1 | 2013 | 10 | 0.110 |
Why?
| | Endocardium | 1 | 2013 | 30 | 0.110 |
Why?
| | Curriculum | 1 | 2020 | 852 | 0.110 |
Why?
| | Milrinone | 1 | 2013 | 25 | 0.110 |
Why?
| | Norwood Procedures | 1 | 2013 | 23 | 0.110 |
Why?
| | Perioperative Care | 1 | 2014 | 126 | 0.110 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2016 | 352 | 0.110 |
Why?
| | Predictive Value of Tests | 4 | 2014 | 1805 | 0.110 |
Why?
| | Hepatic Veins | 1 | 2013 | 31 | 0.110 |
Why?
| | Calcium Channel Blockers | 1 | 2013 | 115 | 0.100 |
Why?
| | Heart Failure | 2 | 2016 | 1963 | 0.100 |
Why?
| | Sotalol | 1 | 2012 | 4 | 0.100 |
Why?
| | Risk | 2 | 2020 | 819 | 0.100 |
Why?
| | Comorbidity | 2 | 2015 | 1473 | 0.100 |
Why?
| | Parents | 1 | 2020 | 1205 | 0.100 |
Why?
| | Syncope, Vasovagal | 1 | 2011 | 3 | 0.100 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 50 | 0.100 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 315 | 0.100 |
Why?
| | Consensus | 1 | 2014 | 532 | 0.100 |
Why?
| | Substance-Related Disorders | 1 | 2020 | 950 | 0.100 |
Why?
| | Incidence | 3 | 2020 | 2335 | 0.100 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2014 | 243 | 0.100 |
Why?
| | Algorithms | 2 | 2020 | 1490 | 0.100 |
Why?
| | Cineangiography | 1 | 2011 | 16 | 0.100 |
Why?
| | Coronary Angiography | 1 | 2013 | 307 | 0.100 |
Why?
| | Patient Safety | 1 | 2014 | 276 | 0.100 |
Why?
| | Adenosine | 1 | 2013 | 203 | 0.100 |
Why?
| | Postoperative Complications | 3 | 2014 | 2161 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2015 | 2800 | 0.090 |
Why?
| | United States | 5 | 2018 | 12295 | 0.090 |
Why?
| | ROC Curve | 2 | 2016 | 451 | 0.090 |
Why?
| | Contraindications | 1 | 2010 | 86 | 0.090 |
Why?
| | Atrial Appendage | 1 | 2010 | 10 | 0.090 |
Why?
| | Clavicle | 1 | 2010 | 31 | 0.090 |
Why?
| | Electric Stimulation | 2 | 2016 | 263 | 0.090 |
Why?
| | Logistic Models | 4 | 2017 | 1856 | 0.090 |
Why?
| | Bacteremia | 1 | 2011 | 159 | 0.090 |
Why?
| | Subclavian Vein | 1 | 2009 | 13 | 0.090 |
Why?
| | Chronic Disease | 1 | 2015 | 1598 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2011 | 538 | 0.080 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 4665 | 0.080 |
Why?
| | Sinoatrial Node | 1 | 2009 | 27 | 0.080 |
Why?
| | Cisapride | 1 | 2008 | 5 | 0.080 |
Why?
| | Quality Improvement | 2 | 2014 | 958 | 0.080 |
Why?
| | Dopamine Antagonists | 1 | 2008 | 22 | 0.080 |
Why?
| | Health Surveys | 1 | 2010 | 446 | 0.080 |
Why?
| | Torsades de Pointes | 1 | 2008 | 17 | 0.080 |
Why?
| | Carotid Artery Injuries | 1 | 2008 | 43 | 0.080 |
Why?
| | Heart-Assist Devices | 1 | 2014 | 486 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4435 | 0.080 |
Why?
| | Heart Rate, Fetal | 1 | 2008 | 21 | 0.080 |
Why?
| | Chronic Pain | 1 | 2011 | 210 | 0.080 |
Why?
| | Mutation | 1 | 2018 | 3364 | 0.070 |
Why?
| | Multivariate Analysis | 3 | 2017 | 1440 | 0.070 |
Why?
| | Myocarditis | 1 | 2008 | 94 | 0.070 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2008 | 120 | 0.070 |
Why?
| | Carotid Arteries | 1 | 2008 | 183 | 0.070 |
Why?
| | Drug Hypersensitivity | 1 | 2008 | 86 | 0.070 |
Why?
| | Myocardial Contraction | 1 | 2008 | 316 | 0.070 |
Why?
| | Heart Diseases | 1 | 2010 | 330 | 0.070 |
Why?
| | Body Weight | 1 | 2011 | 867 | 0.070 |
Why?
| | Hypertension, Pulmonary | 1 | 2018 | 1749 | 0.070 |
Why?
| | Atrial Function | 1 | 2006 | 11 | 0.070 |
Why?
| | Prenatal Diagnosis | 1 | 2008 | 167 | 0.070 |
Why?
| | Gastroesophageal Reflux | 1 | 2008 | 235 | 0.070 |
Why?
| | Family Therapy | 1 | 2006 | 65 | 0.070 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2008 | 242 | 0.070 |
Why?
| | Pregnancy | 3 | 2021 | 5548 | 0.060 |
Why?
| | Cardiopulmonary Bypass | 1 | 2006 | 176 | 0.060 |
Why?
| | Myocardial Ischemia | 1 | 2006 | 237 | 0.060 |
Why?
| | Physician's Role | 1 | 2006 | 199 | 0.060 |
Why?
| | Focus Groups | 1 | 2006 | 393 | 0.060 |
Why?
| | Heart Septum | 1 | 2004 | 26 | 0.060 |
Why?
| | Canada | 2 | 2016 | 335 | 0.060 |
Why?
| | Neural Conduction | 1 | 2004 | 79 | 0.060 |
Why?
| | Bundle-Branch Block | 1 | 2003 | 29 | 0.050 |
Why?
| | Tachycardia, Paroxysmal | 1 | 2002 | 7 | 0.050 |
Why?
| | Ebstein Anomaly | 1 | 2002 | 6 | 0.050 |
Why?
| | Evidence-Based Medicine | 1 | 2006 | 684 | 0.050 |
Why?
| | Diastole | 1 | 2022 | 134 | 0.050 |
Why?
| | Genotype | 1 | 2006 | 1786 | 0.050 |
Why?
| | Exercise | 1 | 2011 | 1609 | 0.050 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2022 | 191 | 0.050 |
Why?
| | Child Abuse | 1 | 2006 | 455 | 0.050 |
Why?
| | Fetal Monitoring | 1 | 2021 | 16 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2012 | 1872 | 0.050 |
Why?
| | Graft Rejection | 1 | 2003 | 533 | 0.040 |
Why?
| | Pennsylvania | 1 | 2020 | 94 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2004 | 1660 | 0.040 |
Why?
| | Philadelphia | 1 | 2019 | 46 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2020 | 118 | 0.040 |
Why?
| | Fluoroscopy | 2 | 2013 | 141 | 0.040 |
Why?
| | Phenotype | 2 | 2018 | 2829 | 0.040 |
Why?
| | Heredity | 1 | 2018 | 12 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2002 | 495 | 0.040 |
Why?
| | Gestational Age | 1 | 2021 | 757 | 0.040 |
Why?
| | Global Health | 1 | 2020 | 290 | 0.040 |
Why?
| | Survival Analysis | 1 | 2000 | 1219 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2016 | 3022 | 0.040 |
Why?
| | Perioperative Period | 1 | 2017 | 49 | 0.040 |
Why?
| | Aged | 5 | 2020 | 19251 | 0.040 |
Why?
| | Reoperation | 1 | 2019 | 525 | 0.040 |
Why?
| | Genetic Markers | 1 | 2018 | 325 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 372 | 0.040 |
Why?
| | Pedigree | 1 | 2018 | 467 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 511 | 0.030 |
Why?
| | Animals | 2 | 2008 | 32102 | 0.030 |
Why?
| | Attitude of Health Personnel | 2 | 2020 | 990 | 0.030 |
Why?
| | Action Potentials | 1 | 2019 | 410 | 0.030 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2016 | 42 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2016 | 119 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1138 | 0.030 |
Why?
| | Protein Conformation | 1 | 2018 | 822 | 0.030 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 209 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2016 | 204 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 962 | 0.030 |
Why?
| | Needs Assessment | 1 | 2016 | 318 | 0.030 |
Why?
| | Phlebography | 1 | 2013 | 40 | 0.030 |
Why?
| | Models, Molecular | 1 | 2018 | 1390 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2013 | 63 | 0.030 |
Why?
| | Sick Sinus Syndrome | 1 | 2012 | 2 | 0.030 |
Why?
| | Hydrops Fetalis | 1 | 2012 | 13 | 0.030 |
Why?
| | Digoxin | 1 | 2012 | 26 | 0.030 |
Why?
| | Electrodiagnosis | 1 | 2012 | 15 | 0.030 |
Why?
| | Live Birth | 1 | 2012 | 48 | 0.030 |
Why?
| | Radiography, Interventional | 1 | 2013 | 111 | 0.030 |
Why?
| | Fetal Death | 1 | 2012 | 49 | 0.030 |
Why?
| | Ventricular Function, Right | 1 | 2014 | 251 | 0.030 |
Why?
| | Ultrasonography, Interventional | 1 | 2013 | 125 | 0.030 |
Why?
| | Boston | 1 | 2012 | 74 | 0.020 |
Why?
| | Benchmarking | 1 | 2013 | 163 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2013 | 308 | 0.020 |
Why?
| | Bradycardia | 1 | 2012 | 48 | 0.020 |
Why?
| | Signal Transduction | 1 | 2004 | 4541 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2013 | 741 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 499 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 445 | 0.020 |
Why?
| | Abortion, Induced | 1 | 2012 | 73 | 0.020 |
Why?
| | Dissection | 1 | 2010 | 52 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2125 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 1870 | 0.020 |
Why?
| | Length of Stay | 1 | 2013 | 958 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 962 | 0.020 |
Why?
| | Seat Belts | 1 | 2008 | 18 | 0.020 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2008 | 8 | 0.020 |
Why?
| | Premature Birth | 1 | 2012 | 278 | 0.020 |
Why?
| | Hematoma | 1 | 2008 | 50 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1178 | 0.020 |
Why?
| | Accidents, Traffic | 1 | 2008 | 170 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2578 | 0.020 |
Why?
| | Oxygenators | 1 | 2006 | 4 | 0.020 |
Why?
| | Manuals as Topic | 1 | 2006 | 13 | 0.020 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2008 | 180 | 0.020 |
Why?
| | Otitis Media | 1 | 2008 | 142 | 0.020 |
Why?
| | Wounds, Nonpenetrating | 1 | 2008 | 225 | 0.020 |
Why?
| | Radiography | 1 | 2008 | 826 | 0.020 |
Why?
| | Ultrasonography | 1 | 2008 | 641 | 0.020 |
Why?
| | Biopsy | 1 | 2008 | 1056 | 0.020 |
Why?
| | Job Satisfaction | 1 | 2006 | 170 | 0.020 |
Why?
| | Body Size | 1 | 2004 | 92 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2392 | 0.010 |
Why?
| | Social Support | 1 | 2006 | 537 | 0.010 |
Why?
| | Body Surface Potential Mapping | 1 | 2002 | 7 | 0.010 |
Why?
| | Equipment Design | 1 | 2004 | 517 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2008 | 607 | 0.010 |
Why?
| | Professional-Family Relations | 1 | 2003 | 138 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2002 | 1227 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2008 | 1484 | 0.010 |
Why?
| | Communication | 1 | 2003 | 750 | 0.010 |
Why?
|
|
Collins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|